Reduction of peak viremia by an integration-defective SIV proviral DNA vaccine in rhesus macaques.

Journal Article

An integrase-defective SIV (idSIV) vaccine delivered by a DNA prime and viral particle boost approach can suppress viral loads (VLs) during the acute infection stage after intravenous SIVmac239 challenge. This study investigated how idSIV DNA and viral particle immunization alone contributed to the suppression of VLs in Chinese rhesus macaques after SIV challenge. Two macaques were immunized with idSIV DNA five times and two macaques were immunized with idSIV viral particles three times. Cellular and humoral immune responses were measured in the vaccinated macaques after immunization. The VLs and CD4+ T cell counts were monitored for 28 weeks after the intravenous SIVmac239 challenge. The SIV-specific T cell responses were only detected in the DNA-vaccinated macaques. However, binding and neutralizing antibodies against autologous and heterologous viruses were moderately better in macaques immunized with viral particles than in macaques immunized with DNA. After the challenge, the mean peak viremia in the DNA group was 2.3 logs lower than that in the control group, while they were similar between the viral particle immunization and control groups. Similar CD4+ T cell counts were observed among all groups. These results suggest that idSIV DNA immunization alone reduces VLs during acute infection after SIV challenge in macaques and may serve as a key component in combination with other immunogens as prophylactic vaccines.

Full Text

Duke Authors

Cited Authors

  • Wang, C; Gao, N; Song, Y; Duan, S; Wang, W; Cong, Z; Qin, C; Jiang, C; Yu, X; Gao, F

Published Date

  • January 2020

Published In

Volume / Issue

  • 64 / 1

Start / End Page

  • 52 - 62

PubMed ID

  • 31544982

Pubmed Central ID

  • 31544982

Electronic International Standard Serial Number (EISSN)

  • 1348-0421

Digital Object Identifier (DOI)

  • 10.1111/1348-0421.12744


  • eng

Conference Location

  • Australia